This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Site-directed spin labeling (SDSL) is a powerful tool for monitoring the structure and dynamics of both soluble and membrane proteins. Measurements of the spectral properties of the paramagnetic nitroxide probe with electron paramagnetic resonance (EPR) spectroscopy provide a wealth of information on the environment in the protein. The HIV-1 protease is a 22 kDa homodimeric protein essential for function of the AIDS virus, and protease inhibitors have been developed into effective HIV drugs. We are particularly interested in the details of HIV-1 protease flap dynamics that can be learned from multifrequency SDSL EPR studies. Earlier SDSL studies of several spin labels at 9.5 GHz do not reveal any significant change in the flap dynamics in the presence or absence of protease inhibitor, contrary to expectration. Preliminary results at 170 GHz do indicate small but discernible differences in the flap dynamics in the presence or absence of inhibitor with the inhibited form showing clear evidence of slower tumbling. Based on these promising initial results we are refining the experimental design in order to enhance the spectral differences. We suggest that complementary studies at 240 GHz will further resolve the spectral sensitivity to the observed small differences in dynamics and will provide a useful means for quantifying the response of HIV-1 protease to the presence of various inhibitors.
Public Health Relevance Statement
Data not available.
NIH Spending Category
BiotechnologyHIV/AIDS
Project Terms
Electron Spin Resonance SpectroscopyEnvironmentExperimental DesignsFundingGrantHIVHIV-1LearningMeasurementMembrane ProteinsMonitorNational Center for Research ResourcesPeptide HydrolasesPharmaceutical PreparationsPrincipal InvestigatorPropertyProtease InhibitorProteinsResearchResearch InfrastructureResourcesSiteSourceSpin LabelsStructureSurgical FlapsTechnologyUnited States National Institutes of Healthbasecostinhibitor/antagonistinterestresponsetool
No Sub Projects information available for 2P41RR016292-11 8095
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P41RR016292-11 8095
Patents
No Patents information available for 2P41RR016292-11 8095
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P41RR016292-11 8095
Clinical Studies
No Clinical Studies information available for 2P41RR016292-11 8095
News and More
Related News Releases
No news release information available for 2P41RR016292-11 8095
History
No Historical information available for 2P41RR016292-11 8095
Similar Projects
No Similar Projects information available for 2P41RR016292-11 8095